Foreign-invested firms calling for withdrawal of reference pricing system

Published: 2002-08-16 07:00:00

Updated: 2002-08-16 07:00:00

Foreign-invested pharmaceutical firms have called for the government to cautiously introduce the reference pricing system (RPS), which has been promoted by the government in a bid to ensure better finance stability in the national health insurance sector, citing that the RPS may aggravate the pub...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK